News and Events Recent News Aug 30, 2019 Arrowhead Pharmaceuticals to Participate in Upcoming September 2019 Conferences Aug 28, 2019 Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection Aug 8, 2019 Arrowhead Pharmaceuticals Doses First Patient in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease View More » Recent Events Oct 18, 2019 Arrowhead Analyst R&D Day 2019 Sep 16, 2019 Global Summit On Cardiology & Heart Diseases Sep 16, 2019 Developing Alpha-1 Antitrypsin Therapeutics; FDA Public Workshop View More »
Aug 28, 2019 Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection
Aug 8, 2019 Arrowhead Pharmaceuticals Doses First Patient in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease